# Induction Chemotherapy for Locally Advanced Esophageal Cancer

> **NCT03110926** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Rochester** · enrollment: 40 (estimated)

## Conditions studied

- Esophageal Carcinoma

## Interventions

- **DRUG:** mFOLFOX6
- **COMBINATION_PRODUCT:** Chemoradiation

## Key facts

- **NCT ID:** NCT03110926
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-06-19
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03110926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03110926, "Induction Chemotherapy for Locally Advanced Esophageal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03110926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*